Baselight
Sign In
YesterdayJun 12Jun 11Jun 10Jun 9Jun 8Jun 7Jun 6Jun 5Jun 4Jun 3Jun 2Jun 1May 31May 30May 29May 28May 27May 26May 25May 24May 23May 22May 21May 20May 19May 18May 17May 16May 15May 14May 13May 12May 11May 10May 9May 8May 7May 6May 5May 4May 3May 2May 1Apr 30Apr 29Apr 28Apr 27Apr 26Apr 24Apr 22Apr 21Apr 20Apr 19Apr 18Apr 17

Stocks

June 13, 2026

Trend Shift01STOCKS

Space Stocks Plunge as SpaceX's Historic Market Debut Triggers Profit-Taking

  • Space-related equities suffered a sharp pullback as investors executed a "sell-the-news" profit-taking wave following SpaceX's initial public offering.
  • AST SpaceMobile plummeted 15.53% to close at $82.41 on massive volume, while BlackSky Technology fell 9.87% to close at $32.42.
  • The selloff indicates capital rotating out of proxy space stocks and directly into the newly public rocket giant.
Space Stocks Plunge as SpaceX's Historic Market Debut Triggers Profit-Taking
Divergence02STOCKS

Salesforce Hits 52-Week Low Despite 44 Upward EPS Revisions

  • Salesforce fell to near its 52-week low amid a broader selloff in subscription-software providers.
  • The stock closed at $165.89 despite 44 upward EPS revisions in the last 7 days, which pushed its current-year consensus EPS from $13.22 to $14.15.
  • This divergence highlights a disconnect between near-term earnings strength and broader market sentiment toward the software sector.
Salesforce Hits 52-Week Low Despite 44 Upward EPS Revisions
Trend Shift03STOCKS

Arm Holdings Completes 23.8% Two-Day Rally on Agentic AI Analyst Upgrades

  • Arm Holdings jumped on analyst upgrades citing growing optimism for "Agentic AI" chips and strong partnerships.
  • The stock rose 11.27% on Friday to close at $380.81, extending its two-day gains to 23.87% from its June 10 close of $307.43.
  • The rally reflects growing market confidence in Arm's high-margin intellectual property licensing model for AI applications.
Arm Holdings Completes 23.8% Two-Day Rally on Agentic AI Analyst Upgrades
Outlier04STOCKS

Enliven Therapeutics Surges 14.3% on FDA Alignment for Leukemia Trial

  • Enliven Therapeutics surged after reaching an agreement with the US FDA on the dose recommendation for its late-stage Chronic Myeloid Leukemia trial.
  • The stock rose 14.30% to close at $46.13 on volume that was 5.96 times its 20-day average.
  • The regulatory alignment clears the path for the company to initiate its Phase 3 study, boosting investor confidence in its clinical pipeline.
Enliven Therapeutics Surges 14.3% on FDA Alignment for Leukemia Trial
Anomaly05STOCKS

First Advantage Volume Jumps 5.2x on S&P SmallCap 600 Inclusion Announcement

  • First Advantage Corporation experienced a volume spike and price gain following the announcement of its selection for S&P SmallCap 600 inclusion.
  • The stock rose 5.98% to close at $16.49 on 3.63 million shares, representing 5.21 times its 20-day average volume.
  • The inclusion, effective June 16, is expected to trigger buying from index-tracking funds seeking to match the index's new composition.
First Advantage Volume Jumps 5.2x on S&P SmallCap 600 Inclusion Announcement
Cross-Signal06STOCKS

Goldman Sachs and JPMorgan Rise as SpaceX Completes Record IPO

  • Shares of Goldman Sachs and JPMorgan Chase rose on June 12 as SpaceX completed the largest IPO in U.S. history.
  • Goldman Sachs rose 2.62% to close at $1,062.75, while JPMorgan Chase advanced 2.31% to close at $320.72.
  • Both banks served as underwriters on the $75 billion offering, positioning them to benefit from substantial underwriting fees.
Goldman Sachs and JPMorgan Rise as SpaceX Completes Record IPO

Share link

Anyone who has the link will be able to view this.